Aims & Scope: Tissue Barriers is the first international cross-disciplinary journal that focuses on the architecture, biological roles and regulation of tissue barriers and intercellular junctions. We publish high quality peer-reviewed articles that cover a wide range of topics including structure and functions of the intestinal, airway, renal, epidermal and other types of tissue barriers, biology of blood-brain and blood-testis barriers, molecular composition and dynamics of epithelial and endothelial junctions, leukocyte, tumor cell and pathogen interactions with epithelial and endothelial layers, non-cellular components of tissue barriers, barrier dysfunctions in diseases and drug delivery across epithelial and endothelial barriers.
Tissue Barriers publishes several categories of articles including: Original Research Papers, Short Communications, Technical Papers, Reviews, Perspectives and Commentaries, Hypothesis and Meeting Reports. Reviews and Perspectives/Commentaries will typically be invited. We also anticipate to publish special issues that are devoted to rapidly developing or controversial areas of research. Suggestions for topics are welcome.
Tissue Barriers has several goals:
Publication office: Taylor & Francis, Group, 530 Walnut Street, Suite 850, Philadelphia, PA 19106.
Tissue Engineering is the premier biomedical journal that brings together the principles of engineering and life sciences to generate new tissue development. It is a forum for groundbreaking scientific research and clinical application from the leading experts in the field. This multidisciplinary journal publishes cutting-edge, breakthrough research and applications on all aspects of tissue growth and regeneration.Anthony Atala, member of the Executive Editorial Board, when interviewed on a 60 Minutes segment, spoke about Regenerative Medicine and current developments in growing body parts. Dr. Atala is the director at Wake Forest Institute for Regenerative Medicine, which is currently growing various tissues for regenerating several body parts including bladders and kidneys, providing endless possibilities for the future of this field.During the interview, Dr. Atala explained “…the hope of the field is that some day we can provide replacement tissues and organs that can be used to help transplant patients who are waiting for organs to survive. Every organ in our body contains special stem cells that are unique to each body part. The key to regeneration is to isolate and then multiply those cells until there are enough to cover a mold of that particle body part.” The field of tissue engineering provides infinite possibilities in bioengineering and life science processes. .
issue Engineering is the premier biomedical journal that brings together the principles of engineering and life sciences to generate new tissue development. It is a forum for groundbreaking scientific research and clinical application from the leading experts in the field. This multidisciplinary journal publishes cutting-edge, breakthrough research and applications on all aspects of tissue growth and regeneration.Anthony Atala, member of the Executive Editorial Board, when interviewed on a 60 Minutes segment, spoke about Regenerative Medicine and current developments in growing body parts. Dr. Atala is the director at Wake Forest Institute for Regenerative Medicine, which is currently growing various tissues for regenerating several body parts including bladders and kidneys, providing endless possibilities for the future of this field.During the interview, Dr. Atala explained “…the hope of the field is that some day we can provide replacement tissues and organs that can be used to help transplant patients who are waiting for organs to survive. Every organ in our body contains special stem cells that are unique to each body part. The key to regeneration is to isolate and then multiply those cells until there are enough to cover a mold of that particle body part.” The field of tissue engineering provides infinite possibilities in .
Tissue Engineering and Regenerative Medicine (TERM) publishes articles online and in print that report substantial and original findings on tissue engineering, medical biomaterials, cells and stem cells for tissue repair, preclinical and clinical studies, and regenerative medicine. The criteria for acceptance of manuscripts are scientific excellence, significance, and interest for the general readership in the tissue engineering and regenerative medicine field. Feature Articles and Editorials are invited only by the Editors.
Tissue & Cell is devoted to original research on the organization of cells, their components and extracellular products, at all levels including the grouping and interrelations of cells, in tissues and organs. Emphasis is placed on cell biological aspects of structure, function and behaviour of cells, and primarily morphological accounts must include substantially new information of general interest. Timely review articles on topics of particular interest, and accounts of new techniques and applications that deal with aspects of cell structure and function are invited.A new service for Authors - Submit your article onlineTo order this journal online, visit http://intl.elsevierhealth.com/journals/ticeBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Tizard Learning Disability Review (TLDR) is an accessible, readable and challenging high-quality source of information and intelligence for those researching and working in the field of learning/intellectual disabilities.
Tobacco Control aims to study the nature and consequences of tobacco use worldwide; tobacco's effects on population health, the economy, the environment, and society; efforts to prevent and control the global tobacco epidemic through population level education and policy changes; the ethical dimensions of tobacco control policies; and the activities of the tobacco industry and its allies.